Alector, Inc. (NASDAQ: ALEC)
$1.6600
+0.0250 ( -2.35% ) 502.3K
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
Market Data
Open
$1.6600
Previous close
$1.6350
Volume
502.3K
Market cap
$167.38M
Day range
$1.6350 - $1.7850
52 week range
$1.6100 - $7.7800
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Jun 04, 2024 |
| 4 | Insider transactions | 1 | Jun 04, 2024 |
| 4 | Insider transactions | 1 | Jun 04, 2024 |
| 4 | Insider transactions | 1 | Jun 04, 2024 |
| 4 | Insider transactions | 1 | May 31, 2024 |
| 8-k | 8K-related | 13 | May 08, 2024 |
| 10-q | Quarterly Reports | 48 | May 08, 2024 |
| 4 | Insider transactions | 1 | May 02, 2024 |
| ars | Annual reports | 1 | Apr 25, 2024 |
| def | Proxies and info statements | 16 | Apr 25, 2024 |